Diagnosis and treatment of primary immunodeficiency disease in patients with gastrointestinal symptoms

Clinical Immunology

Volumn 139, Issue 3, 2011, Pages 238-248

  Kobrynski, L J ^a   Mayer, L ^b  

^a Emory Children's Center   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Chronic and acute diarrhea; Gastrointestinal infections; Immunoglobulin replacement therapy; Inflammatory bowel diseases; Malabsorption; Primary immunodeficiency diseases

Indexed keywords

IMMUNOGLOBULIN;

ACALCULOUS CHOLECYSTITIS; ACUTE DIARRHEA; APPENDICITIS; ATROPHIC GASTRITIS; BLOODY DIARRHEA; CELIAC DISEASE; CHRONIC DIARRHEA; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; CONSTIPATION; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENTERITIS; ENTEROPATHY; ENTEROVIRUS INFECTION; FAILURE TO THRIVE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GIARDIASIS; GRANULOMATOUS INFLAMMATION; HEPATITIS; HUMAN; HYPER IGM SYNDROME; I KAPPA B KINASE GAMMA DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOTHERAPY; INFECTIOUS DIARRHEA; INTESTINE VILLUS ATROPHY; IPEX SYNDROME; LEUKOCYTE COUNT; LIVER ABSCESS; MALABSORPTION; MICROORGANISM; NODULAR LYMPHOMATOSIS; NUTRITIONAL INTOLERANCE; PERNICIOUS ANEMIA; PERSISTENT INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SCLEROSING CHOLANGITIS; SEVERE COMBINED IMMUNODEFICIENCY; STEATORRHEA; STOMACH CANCER; ULCERATIVE COLITIS; X LINKED AGAMMAGLOBULINEMIA;

B-LYMPHOCYTES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; PHAGOCYTES; T-LYMPHOCYTES;

EID: 79955973717     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.01.008     Document Type: Review

References (80)

1. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., Hammarstrom L., Nonoyama S., Ochs H.D., Puck J.M., Roifman C., Seger R., Wedgwood J. International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee, Primary Immunodeficiency Diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol. 2007, 120:776-794.
2. Boyle J.M., Buckley R.H. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol. 2007, 27:497-502.
3. Immune Deficiency Foundation Diagnostic and clinical care guidelines for primary immunodeficiency diseases 2006, Available at, Accessed March 9, 2009. http://www.primaryimmune.org/publications/book_diag/IDF_Diagnostic_and_Clinical_Care_Guidelines-Final.pdf.
4. Yarmohammadi H., Estrella L., Doucette J., Cunningham-Rundles C. Recognizing primary immune deficiency in clinical practice. Clin. Vaccine Immunol. 2006, 13:329-332.
5. Plebani A., Soresina A., Rondelli R. Italian Pediatric Group for XLA-Italian Association of Pediatric Hematology and Oncology, Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol. 2002, 104:221-230.
6. Johnston S.L., Hill S.J., Lock R.J., Dwight J.F., Unsworth D.J., Gompels M.M. Echocardiographic abnormalities in primary antibody deficiency. Postgrad. Med. J. 2004, 80:214-218.
7. Seymour B., Miles J., Haeney M. Primary antibody deficiency and diagnostic delay. J. Clin. Pathol. 2005, 58:546-547.
8. Wood P., Stanworth S., Burton J., Jones A., Peckham D.G., Green T., Hyde C., Chapel H. UK Primary Immunodeficiency Network, recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin. Exp. Immunol. 2007, 149:410-423.
9. Boyle M.L., Scalchunes C. Impact of intravenous immunoglobulin (IVIG) treatment among patients with primary immunodeficiency disease. Pharm. Policy Law 2008, 10:133-146.
10. Lai Ping So A., Mayer L. Gastrointestinal manifestations of primary immunodeficiency disorders. Semin. Gastrointest. Dis. 1997, 8:22-32.
11. McCabe R.P. Gastrointestinal manifestations of non-AIDS immunodeficiency. Curr. Treat Options Gastroenterol. 2002, 5:17-25.
12. Kalha I., Sellin J.H. Common variable immunodeficiency and the gastrointestinal tract. Curr. Gastroenterol. Rep. 2004, 6:377-383.
13. Spahn T.W., Kucharzik T. Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 2004, 53:456-465.
14. Cerutti A., Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008, 28:740-750.
15. Kadaoui K.A., Corthésy B. Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment. J. Immunol. 2007, 179:7751-7757.
16. Bollinger R.R., Everett M.L., Palestrant D., Love S.D., Lin S.S., Parker W. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 2003, 109:580-587.
17. Torgerson T.R. Immune dysregulation in primary immunodeficiency disorders. Immunol. Allergy Clin. North Am. 2008, 28:315-327.
18. Kätkä K., Eskola J., Granfors K., Koistinen J., Toivanen A. Serum IgA deficiency and anti-IgA antibodies in pernicious anemia. Clin. Immunol. Immunopathol. 1988, 46:55-60.
19. American Gastroenterological Association American Gastroenterological Association medical position statement: celiac sprue. Gastroenterology 2001, 120:1522-1525.
20. Dahlbom I., Korponay-Szabó I.R., Kovács J.B., Szalai Z., Mäki M., Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J. Pediatr. Gastroenterol. Nutr. 2010, 50:140-146.
21. Wanchu A., Bambery P., Sud A., Chawla Y., Vaiphei K., Deodhar S.D. Autoimmune hepatitis in a patient with primary Sjogren's syndrome and selective IgA deficiency. Trop. Gastroenterol. 1998, 19:62-63.
22. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J. Clin. Immunol. 1989, 9:22-33.
23. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 1999, 92:34-48.
24. Conley M.E., Park C.L., Douglas S.D. Childhood common variable immunodeficiency disease. J. Pediatr. 1986, 108:915-922.
25. Primary Immunodeficiency Association Understanding hyper-IgM syndrome 2009, Available at:, Accessed May 15, 2009. http://www.pia.org.uk/publications/general_publications/hyperigm_syndrome.htm.
26. Winkelstein J.A., Marino M.C., Ochs H., Fuleihan R., Scholl P.R., Geha R., Stiehm E.R., Conley M.E. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003, 82:373-384.
27. Kerkar N., Miloh T. Sclerosing cholangitis: pediatric perspective. Curr. Gastroenterol. Rep. 2010, 12:195-202.
28. Hayward A.R., Levy J., Facchetti F., Notarangelo L., Ochs H.D., Etzioni A., Bonnefoy J.Y., Cosyns M., Weinberg A. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 1997, 158:977-983.
29. Bonilla F.A., Bernstein I.L., Khan D.A., Ballas Z.K., Chinen J., Frank M.M., Kobrynski L.J., Levinson A.I., Mazer B., Nelson R.P., Orange J.S., Routes J.M., Shearer W.T., Sorensen R.U. American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology, Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 2005, 94(Suppl. 1):S1-S63.
30. Washington K., Stenzel T.T., Buckley R.H., Gottfried M.R. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am. J. Surg. Pathol. 1996, 20:1240-1252.
31. Ege M., Ma Y., Manfras B., Kalwak K., Lu H., Lieber M.R., Schwarz K., Pannicke U. Omenn syndrome due to ARTEMIS mutations. Blood 2005, 105:4179-4186.
32. Aleman K., Noordzij J.G., de Groot R., van Dongen J.J., Hartwig N.G. Reviewing Omenn syndrome. Eur. J. Pediatr. 2001, 160:718-725.
33. Villa A., Sobacchi C., Vezzoni P. Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies. I.M.A.J. 2002, 4:218-221.
34. Gomez L., Le Deist F., Blanche S., Cavazzana-Calvo M., Griscelli C., Fischer A. Treatment of Omenn syndrome by bone marrow transplantation. J. Pediatr. 1995, 127:76-81.
35. Hönig M., Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr. Opin. Rheumatol. 2006, 18:383-388.
36. Puzenat E., Rohrlich P., Thierry P., Girardin P., Taghian M., Ouachee M., Plouvier E., Fischer A., Humbert P., Aubin F. Omenn syndrome: a rare case of neonatal erythroderma. Eur. J. Dermatol. 2007, 17:137-139.
37. Smahi A., Courtois G., Rabia S.H., Doffinger R., Bodemer C., Munnich A., Casanova J.-L., Israel A. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum. Mol. Genet. 2002, 11:2371-2375.
38. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor kB essential modulator mutation. J. Allergy Clin. Immunol. 2004, 113:725-733.
39. Orange J.S., Brodeur S.R., Jain A., Bonilla F.A., Schneider L.C., Kretschmer R., Nurko S., Rasmussen W.L., Köhler J.R., Gellis S.E., Ferguson B.M., Strominger J.L., Zonana J., Ramesh N., Ballas Z.K., Geha R.S. Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations. J. Clin. Invest. 2002, 109:1501-1509.
40. Risma K.A., Deering R., Monaco-Shawver L., Heltzer M., Burnham J., Niemela J., Fleisher T.A., Bleesing J.J., Putnam P.E., Jain A., Orange J.S. Ectodermal dysplasia with immunodeficiency and lymphedema, but not osteopetrosis, is associated with a unique NF-kB Essential Modulator (NEMO) mutation. Abstract presented at the 2005 Primary Immunodeficiency Diseases Consortium Conference 2009, Available at:, Accessed April 20, 2009. http://www.clinimmsoc.org/meetings/satellite05pid/risma.pdf.
41. Winkelstein J.A., Marino M.C., Johnston R.B., Boyle J., Curnutte J., Gallin J.I., Malech H.L., Holland S.M., Ochs H., Quie P., Buckley R.H., Foster C.B., Chanock S.J., Dickler H. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine (Baltimore) 2000, 79:155-169.
42. Lublin M., Bartlett D.L., Danforth D.N., Kauffman H., Gallin J.I., Malech H.L., Shawker T., Choyke P., Kleiner D.E., Schwartzentruber D.J., Chang R., DeCarlo E.S., Holland S.M. Hepatic abscess in patients with chronic granulomatous disease. Ann. Surg. 2002, 235:383-391.
43. Rosenzweig S.D., Holland S.M. Phagocyte immunodeficiencies and their infections. J. Allergy Clin. Immunol. 2004, 113:620-626.
44. Barton L.L., Moussa S.L., Villar R.G., Hulett R.L. Gastrointestinal complications of chronic granulomatous disease: case report and literature review. Clin. Pediatr. (Philadelphia) 1998, 37:231-236.
45. Marciano B.E., Rosenzweig S.D., Kleiner D.E., Anderson V.L., Darnell D.N., Anaya-O'Brien S., Hilligoss D.M., Malech H.L., Gallin J.I., Holland S.M. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004, 114:462-468.
46. Myers A.K., Perroni L., Costigan C., Reardon W. Clinical and molecular findings in IPEX syndrome. Arch. Dis. Child. 2006, 91:63-64.
47. Roifman C.M. Human IL-2 receptor alpha chain deficiency. Pediatr. Res. 2000, 48:6-11.
48. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., Verbsky J.W. CD25 deficiency causes in immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 2007, 119:482-487.
49. Sharfe N., Dadi H.K., Shahar M., Roifman C.M. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3168-3171.
50. Kappelman M.D., Rifas-Shiman S.L., Kleinman K., Ollendorf D., Bousvaros A., Grand R.J., Finkelstein J.A. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin. Gastroenterol. Hepatol. 2007, 5:1424-1429.
51. Santaella M.L., Cox P.R., Colón M., Ramos C., Disdier O.M. Rheumatologic manifestations in patients with selected primary immunodeficiencies evaluated at the University Hospital. P. R. Health Sci. J. 2005, 24:191-195.
52. Marks D.J., Harbord M.W., MacAllister R., Rahman F.Z., Young J., Al-Lazikani B., Lees W., Novelli M., Bloom S., Segal A.W. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006, 367:668-678.
53. Marks D.J., Miyagi K., Rahman F.Z., Novelli M., Bloom S.L., Segal A.W. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am. J. Gastroenterol. 2009, 104:117-124.
54. Schäppi M.G., Smith V.V., Goldblatt D., Lindley K.J., Milla P.J. Colitis in chronic granulomatous disease. Arch. Dis. Child. 2001, 84:147-151.
55. Liu S., Russo P.A., Baldassano R.N., Sullivan K.E. CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous disease. Inflamm. Bowel Dis. 2009, 15:1213-1217.
56. Cannioto Z., Berti I., Martelossi S., Bruno I., Giurici N., Crovella S., Ventura A. IBD and IBD mimicking enterocolitis in children younger than 2years of age. Eur. J. Pediatr. 2009, 168:149-155.
57. Meerhof L.J., Roos D. Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test. J. Leukoc. Biol. 1986, 39:699-711.
58. Martin Mateos M.A., Alvaro M., Giner M.T., Plaza A.M., Sierra J.I., Muňoz-Lopez F. Chronic granulomatous disease: six new cases. Allergol. Immunopathol. (Madr.) 1998, 26:241-249.
59. Johansen K.S. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers. Acta. Pathol. Microbiol. Immunol. Scand. C 1983, 91:349-354.
60. Vowells S.J., Sekhasaria S., Malech H.L., Shalit M., Fleisher T.A. Flow cytometric analysis of the granulocyte respiratory burst: a comparison of fluorescent probes. J. Immunol. Meth. 1995, 178:89-97.
61. Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory cells. J. Allergy Clin. Immunol. 2007, 120:744-750.
62. Daniels J.A., Lederman H.M., Maitra A., Montgomery E.A. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am. J. Surg. Pathol. 2007, 31:1800-1812.
63. Jaggi P., Freeman A.F., Katz B.Z. Chronic granulomatous disease presenting with eosinophilic inflammation. Pediatr. Infect. Dis. J. 2005, 24:1020-1021.
64. Zullo A., Romiti A., Rinaldi V., Vecchione A., Tomao S., Aiuti F., Frati L., Luzi G. Gastric pathology in patients with common variable immunodeficiency. Gut 1999, 45:77-81.
65. Atarod L., Raissi A., Aghamohammadi A., Farhoudi A., Khodadad A., Moin M., Pourpak Z., Movahedi M., Gharagozlou M., Rezaei N. A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10year period (1990-2000), in Children Hospital Medical Center. Iran. J. Allergy Asthma Immunol. 2003, 2:75-79.
66. Ballow M. Approach to the patient with recurrent infections. Clin. Rev. Allergy Immunol. 2008, 34:129-140.
67. American Gastroenterological Association American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology 1999, 116:1461-1463.
68. Huang J.S., Noack D., Rae J., Ellis B.A., Newbury R., Pong A.L., Lavine J.E., Curnutte J.T., Bastian J. Chronic granulomatous disease caused by a deficiency in p47phox mimicking Crohn's disease. Clin. Gastroenterol. Hepatol. 2004, 2:690-695.
69. Primary Immunodeficiency Resource Center 10 warning signs of primary immunodeficiency 2008, Available at:, Accessed October 7, 2009. http://www.info4pi.org/patienttopatient/pdf/10_warnings_poster_eng.pdf.
70. Misbah S.A., Chapel H.M., Johnston B.J., Ali M.H., Reed P.I., O'Sullivan D. Attempt to reverse atrophic gastritis associated with common variable immunodeficiency. J. Clin. Gastroenterol. 1992, 15:354-355.
71. Leung D.Y., Kelly C.P., Boguniewicz M., Pothoulakis C., LaMont J.T., Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J. Pediatr. 1991, 118:633-637. (Part 1).
72. Hassett J., Meyers S., McFarland L., Mulligan M.E. Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. Clin. Infect. Dis. 1995, 20(Suppl. 2):S266-S268.
73. Onbaşi K., Günşar F., Sin A.Z., Ardeniz O., Kokuludaǧ A., Sebik F. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis. Turk. J. Gastroenterol. 2005, 16:111-113.
74. McEldowney S.J., Moss M.H. An uncommon presentation of chronic diarrhea and common variable immunodeficiency improved with IVIG therapy. J. Allergy Clin. Immunol. 2006, 117 (Suppl):S174.
75. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol. Allergy Clin. North Am. 2008, 28:413-437.
76. Stiehm E.R., Chin T.W., Haas A., Peerless A.G. Infectious complications of the primary immunodeficiencies. Clin. Immunol. Immunopathol. 1986, 40:69-86.
77. Elnachef N., McMorris M., Chey W.D. Successful treatment of common variable immunodeficiency disorder-associated diarrhea with budesonide: a case report. Am. J. Gastroenterol. 2007, 102:1322-1325.
78. Nos P., Bastida G., Beltran B., Aguas M., Ponce J. Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha. Am. J. Gastroenterol. 2006, 101:2165-2166.
79. Chua I., Standish R., Lear S., Harbord M., Eren E., Raeiszadeh M., Workman S., Webster D. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin. Exp. Immunol. 2007, 150:306-311.
80. Crum N.F., Lederman E.R., Wallace M.R. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 2005, 84:291-302.